<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00733759</url>
  </required_header>
  <id_info>
    <org_study_id>IC/CLS10</org_study_id>
    <nct_id>NCT00733759</nct_id>
  </id_info>
  <brief_title>Contrast Echocardiography in Patients With Pulmonary Arteriovenous Malformations (PAVMs)</brief_title>
  <official_title>The Evaluation of Intra-cardiac Shunts in Patients With Pulmonary Arteriovenous Malformations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Imperial College London</source>
  <brief_summary>
    <textblock>
      Pulmonary arteriovenous malformations (PAVMs) are thin-walled abnormal vessels which provide
      direct capillary-free communications between the pulmonary and systemic circulations.
      Patients with PAVMs have usually have low blood oxygen levels and are at risk of other
      complications including strokes, brain abscesses, pregnancy-related complications and
      haemorrhage. We hypothesise that the complications of PAVM patients arise from their PAVMs
      and not the more recognised intracardiac forms of shunting. We propose to perform
      echocardiograms to enable assessment of the presence of other causes of capillary-free
      communications between the pulmonary and systemic circulations.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Unable to recruit patients due to technical issues following submission
  </why_stopped>
  <start_date type="Anticipated">February 2004</start_date>
  <completion_date type="Actual">March 2008</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">0</enrollment>
  <condition>Pulmonary Arteriovenous Malformations</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with pulmonary arteriovneous malformations
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with pulmonary arteriovenous malformations (PAVMs)

        Exclusion Criteria:

          -  unable to provide informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claire L Shovlin</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imperial College London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Imperial College Hammersmith Campus</name>
      <address>
        <city>London</city>
        <zip>W12 0NN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>August 12, 2008</study_first_submitted>
  <study_first_submitted_qc>August 12, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 13, 2008</study_first_posted>
  <last_update_submitted>October 7, 2019</last_update_submitted>
  <last_update_submitted_qc>October 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemangioma</mesh_term>
    <mesh_term>Arteriovenous Malformations</mesh_term>
    <mesh_term>Arteriovenous Fistula</mesh_term>
    <mesh_term>Congenital Abnormalities</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

